Literature DB >> 15039087

Understanding global changes in histone H1 phosphorylation using mass spectrometry.

Leesa J Deterding1, Geoffrey C Banks, Kenneth B Tomer, Trevor K Archer.   

Abstract

Histone post-translational modifications have been implicated in a variety of biological processes such as gene expression, DNA replication, and chromatin assembly. The modifications include methylation, acetylation, phosphorylation, ubiquitination, glycosylation, and ADP-ribosylation. For several years, we have been investigating the role of histone H1 phosphorylation in transcription using the hormone inducible mouse mammary tumor virus (MMTV) promoter. When mouse cells were exposed to prolonged treatment with dexamethasone, a significant decrease in the level of histone H1 phosphorylation was observed. Traditionally, Western analyses with anti-histone H1 and phospho-specific H1 antibodies were performed to observe changes in phosphorylation levels of the bulk H1 histones. More recently, we have applied electrospray ionization mass spectrometry to the analysis of histone H1 isoforms. Utilizing this approach, we have investigated the phosphorylation state of the specific H1 isoforms before and after prolonged treatment with dexamethasone. Specifically, we could determine that the relative phosphorylation levels of the histone H1.3, H1.4, and H1.5 isoforms decrease after prolonged hormone exposure. Recent advancements in mass spectrometry have proven invaluable toward the analysis of post-translational modifications on proteins. The continued developments in the area of mass spectrometry should provide new insights into not only the function of proteins but also into the basic regulatory mechanisms that control cellular functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039087     DOI: 10.1016/j.ymeth.2003.10.020

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

Review 1.  Chromatin remodeling during glucocorticoid receptor regulated transactivation.

Authors:  Heather A King; Kevin W Trotter; Trevor K Archer
Journal:  Biochim Biophys Acta       Date:  2012-03-06

2.  Assaying pharmacodynamic endpoints with targeted therapy: flavopiridol and 17AAG induced dephosphorylation of histone H1.5 in acute myeloid leukemia.

Authors:  Liwen Wang; Sean W Harshman; Shujun Liu; Chen Ren; Hua Xu; Larry Sallans; Michael Grever; John C Byrd; Guido Marcucci; Michael A Freitas
Journal:  Proteomics       Date:  2010-12       Impact factor: 3.984

3.  C-terminal phosphorylation of murine testis-specific histone H1t in elongating spermatids.

Authors:  Kristie L Rose; Andra Li; Irina Zalenskaya; Yun Zhang; Emmanuel Unni; Kim C Hodgson; Yaping Yu; Jeffrey Shabanowitz; Marvin L Meistrich; Donald F Hunt; Juan Ausió
Journal:  J Proteome Res       Date:  2008-08-13       Impact factor: 4.466

4.  Global changes in and characterization of specific sites of phosphorylation in mouse and human histone H1 Isoforms upon CDK inhibitor treatment using mass spectrometry.

Authors:  Leesa J Deterding; Maureen K Bunger; Geoffrey C Banks; Kenneth B Tomer; Trevor K Archer
Journal:  J Proteome Res       Date:  2008-04-17       Impact factor: 5.370

Review 5.  H1 histones: current perspectives and challenges.

Authors:  Sean W Harshman; Nicolas L Young; Mark R Parthun; Michael A Freitas
Journal:  Nucleic Acids Res       Date:  2013-08-14       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.